Rescinnamine
- Level
- Commodity
- Parent
- 51434200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51434204This classification denotes an antihypertensive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q6W1F7DJ2D. European Medicines Agency schedules Rescinnamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10285MIG. Rescinnamine generally arises in the molecular formula C35H42N2O9. The term RESCINNAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, no. 12, 1959, list 3.) RESCINNAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rescinnamine under HS 29399900 and SITC 54149. As of Q4 2014, RESCINNAMINE remains the US FDA Preferred Term for this commodity. Rescinnamine bears US NLM identifiers UMLS ID C0035167 and NCI Concept Code C61923. SMILES: O(C1C(C2C(CN3C(C2)c2[nH]c4c(c2CC3)ccc(OC)c4)CC1OC(=O)/C=C/c1cc(OC)c(OC)c(OC)c1)C(=O)OC)C.
Same parent
Under 51434200 · 7Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.